Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...

Saluda Medical announced that it closed a $100 million financing to support its novel closed-loop, dose-control ...

CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.

Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...

BD today announced it appointed Pamela Spikner as senior VP, chief accounting officer, and controller, effective January 20.

It’s incredibly rewarding to build in the medtech space, but some data suggests the average medical device requires $31 ...

Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.

Avinger announced this week it laid off 36 employees as part of a corporate restructuring to focus on new technology.

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...